These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2059336)

  • 1. Activation of the complement cascade by trypsin.
    Roxvall L; Bengtson A; Sennerby L; Heideman M
    Biol Chem Hoppe Seyler; 1991 Apr; 372(4):273-8. PubMed ID: 2059336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
    Roxvall LI; Bengtson LA; Heideman JM
    Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin generation in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    J Surg Res; 1989 Aug; 47(2):138-43. PubMed ID: 2787873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative effect of methylprednisolone given during lung surgery on plasma concentrations of C3a and C5a.
    Mikawa K; Ikegaki J; Maekawa N; Hoshina H; Tanaka O; Goto R; Obara H; Kusunoki M
    Scand J Thorac Cardiovasc Surg; 1990; 24(3):229-33. PubMed ID: 2293363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids.
    Bengtsson A; Bengtson JP; Rydenhag A; Roxvall L; Heideman M
    J Intern Med; 1990 Aug; 228(2):173-6. PubMed ID: 2394968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early complement system activation and neutrophil priming in acute pancreatitis: participation of trypsin.
    Acioli JM; Isobe M; Kawasaki S
    Surgery; 1997 Nov; 122(5):909-17. PubMed ID: 9369891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course analysis of C3a and C5a quantifies the coupling between the upper and terminal Complement pathways in vitro.
    Morad HO; Belete SC; Read T; Shaw AM
    J Immunol Methods; 2015 Dec; 427():13-8. PubMed ID: 26391915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement anaphylatoxin C3a and C5a formation in premature children with respiratory distress.
    Enskog A; Bengtsson A; Bengtson JP; Heideman M; Andreasson S; Larsson L
    Eur J Pediatr; 1996 Jan; 155(1):41-5. PubMed ID: 8750809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration.
    Arnestad JP; Hyllner M; Bengtson JP; Tylman M; Mollnes TE; Bengtsson A
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):811-5. PubMed ID: 9698958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
    Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
    Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
    J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
    Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
    J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
    Williams JJ; Yellin SA; Slotman GJ
    Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the complement anaphylatoxins in the recruitment of eosinophils.
    DiScipio RG; Schraufstatter IU
    Int Immunopharmacol; 2007 Dec; 7(14):1909-23. PubMed ID: 18039528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.